Thermo Fisher Scientific
TMO
1,024 hedge funds and large institutions have $48.9B invested in Thermo Fisher Scientific in 2016 Q1 according to their latest regulatory filings, with 90 funds opening new positions, 382 increasing their positions, 397 reducing their positions, and 59 closing their positions.
53% more first-time investments, than exits
New positions opened: 90 | Existing positions closed: 59
2.31% more ownership
Funds ownership: 89.05% → 91.36% (+2.3%)
2% more funds holding
Funds holding: 1,006 → 1,024 (+18)
4% less repeat investments, than reductions
Existing positions increased: 382 | Existing positions reduced: 397
8% less capital invested
Capital invested by funds: $53B → $48.9B (-$4.15B)
13% less funds holding in top 10
Funds holding in top 10: 88 → 77 (-11)
29% less call options, than puts
Call options by funds: $100M | Put options by funds: $141M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal London Asset Management
United Kingdom
|
+$1.82B |
| 2 |
Select Equity Group
New York
|
+$191M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$170M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$133M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$83.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCM
Glenview Capital Management
New York
|
-$311M |
| 2 |
UBS AM
Chicago,
Illinois
|
-$221M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$202M |
| 4 |
Prudential Financial
Newark,
New Jersey
|
-$126M |
| 5 |
Capital Research Global Investors
Los Angeles,
California
|
-$116M |
TMO Hedge Fund Activity: Q1 2016 in Review
1,024 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q1 2016, worth a combined $48.9B — down 7.8% from $53B a quarter earlier.
Buyers outnumbered sellers: 90 funds opened new TMO positions and 59 closed out — a net gain of 31 holders — while 382 added to existing stakes and 397 trimmed.
The largest buyer was Royal London Asset Management, adding an estimated $1.82B. The largest seller was Glenview Capital Management, cutting an estimated $311M.
- 1,024 institutional investors held Thermo Fisher Scientific (TMO) as of Q1 2016, up from 1,006 in Q4 2015.
- Funds reported $48.9B of Thermo Fisher Scientific stock for Q1 2016, down 7.8% quarter-over-quarter.
- 90 funds opened new Thermo Fisher Scientific positions in Q1 2016 and 59 closed out, a net change of +31 holders.
- The largest Thermo Fisher Scientific buyer in Q1 2016 was Royal London Asset Management, an estimated $1.82B added.
- The largest Thermo Fisher Scientific seller in Q1 2016 was Glenview Capital Management, an estimated $311M sold.
Based on aggregated 13F filings for Q1 2016.